A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
University of Alabama at Birmingham
Ossium Health, Inc.
Orca Biosystems, Inc.
University of Miami
Children's Hospital Medical Center, Cincinnati
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Institut Claudius Regaud
University of Iowa
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
University of Alabama at Birmingham
University of Alabama at Birmingham
Affiliated Hospital of Qinghai University
Massachusetts General Hospital
BlossomHill Therapeutics
Dana-Farber Cancer Institute
University Hospital, Bordeaux
University of Nebraska
Northwestern University
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Cogent Biosciences, Inc.
Hikma Pharmaceuticals LLC
University Health Network, Toronto
University Hospital, Clermont-Ferrand
Zhujiang Hospital
Chongqing Precision Biotech Co., Ltd